Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durability of immunogenicity and effectiveness of heterologous COVID-19 vaccination in kidney transplant recipients
TCTR20220511002Phase 3Completed
- Sponsor
- National Research Council of Thailand
- Start
- Apr 2022
- Countries
- 1
01
Overview
Phase 3 trial in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Started Apr 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20220511002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220511002.